'Active' year for Israeli biz in London

Seventeen Israeli companies joined the London Stock Exchange this year, according to Graham Dallas, a senior manager for International Business Development with the exchange.

By LEAH GRANOF
December 25, 2006 08:05

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Seventeen Israeli companies joined the London Stock Exchange this year, according to Graham Dallas, a senior manager for International Business Development with the exchange. Although the number of new companies listing on the London Exchange was slightly lower than last year, the companies represent a greater number of large companies and therefore engage in bigger transactions, Dallas noted. Atlas Estates, Gold Frost, MTI Wireless Edge, Playtech, Atelis, Bateman Litwin, Summit Germany, Nanette Real Estate, Axis Mobile, Nikanor pic, Target Resources, SimiGon, Plaza Center, Mirland, R.G.I. and Polymer Logistics. All but Plaza Center were listed on the LSE's AIM division.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS